Onkologicky ustav sv. Alzbety, s.r.o.
Bratislava, Slovakia
Cancer treatment center in Bratislava
Heydukova 2157/10, 812 50 Bratislava
About Onkologicky ustav sv. Alzbety, s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
6
Central European Cooperative Oncology Group
3
European Organisation for Research and Treatment of Cancer - EORTC
2
Baxalta now part of Shire
1
Bayer
1
EMD Serono
1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
1
Hoffmann-La Roche
1
Clinical Trials at Onkologicky ustav sv. Alzbety, s.r.o.
During the past decade, Onkologicky ustav sv. Alzbety, s.r.o. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy Plus Surgery in Treating Women With Breast Cancer
1996-10-01
2009-03-01
Completed
450
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
1997-11-01
Completed
859
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
2002-04-01
Terminated
351
Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer
2005-04-01
2006-09-01
Completed
50
Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine
2002-06-01
2005-10-01
Completed
430
2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
2008-04-01
2014-12-01
Completed
564
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
2009-12-01
Completed
107
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Onkologicky ustav sv. Alzbety, s.r.o." #1 sponsor was "Pfizer" with 6 trials, followed by "Central European Cooperative Oncology Group" with 3 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologicky ustav sv. Alzbety, s.r.o."
#1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Onkologicky ustav sv. Alzbety, s.r.o.
According to Clinical.Site data, the most researched conditions in "Onkologicky ustav sv. Alzbety, s.r.o." are
"Breast Cancer" (3 trials), "Early Breast Cancer" (2 trials), "Fever, Sweats, and Hot Flashes" (2 trials), "Infection" (2 trials) and "Leukemia" (2 trials). Many other conditions were trialed in "Onkologicky ustav sv. Alzbety, s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at Onkologicky ustav sv. Alzbety, s.r.o.
Most popular intervention types in "Onkologicky ustav sv. Alzbety, s.r.o." are "Drug" (14 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cetuximab" (2 trials), "Encorafenib" (2 trials), "PF-05280014" (2 trials), "5-FU" (1 trials) and "A licensed human normal immunoglobulin other than HYQVIA for IV or SC infusion or an alternative treatment" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Onkologicky ustav sv. Alzbety, s.r.o.
The vast majority of trials in "Onkologicky ustav sv. Alzbety, s.r.o." are
10 trials for "All" genders and 6 trials for "Female" genders.
Clinical Trials Status at Onkologicky ustav sv. Alzbety, s.r.o.
Currently, there are NaN active trials in "Onkologicky ustav sv. Alzbety, s.r.o.".
undefined are not yet recruiting,
5 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Onkologicky ustav sv. Alzbety, s.r.o.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Onkologicky ustav sv. Alzbety, s.r.o., 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".